Abstract
The objective of this study was to compare the predictive performance of bleeding risk-estimation tools in a cohort of patients with atrial fibrillation (AF) undergoing anticoagulation.
| Original language | English |
|---|---|
| Pages (from-to) | 861-7 |
| Number of pages | 7 |
| Journal | Journal of the American College of Cardiology |
| Volume | 60 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 28 Aug 2012 |
Bibliographical note
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.Keywords
- Randomized Controlled Trials as Topic
- Anticoagulants
- Humans
- Aged
- Predictive Value of Tests
- Middle Aged
- Warfarin
- Atrial Fibrillation
- Hemorrhage
- Male
- Female
- Risk Assessment
Fingerprint
Dive into the research topics of 'Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver